Human PMNs exhibit greater engulfment, NETosis, and enhanced migration when incubated with nontypeable Haemophilus

Kathryn Q Wilbanks1, Joshua Flesher1, Steven D Goodman1,2

  • 1Center for Microbe and Immunity Research, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States.

Frontiers in Microbiology
|December 15, 2025
PubMed

Insights

A novel monoclonal antibody releases bacteria from biofilms, making them vulnerable to immune cells. This antibody treatment eradicates bacteria in animal models, highlighting the power of innate immunity against biofilm infections.

Area of Science:

  • Microbiology and Immunology
  • Bacterial Biofilm Research
  • Infectious Disease Therapeutics

Background:

  • Biofilm-resident bacteria are protected by their matrix, evading antibiotics and immune responses.
  • Releasing bacteria from biofilms enhances susceptibility to antimicrobial agents and host defenses.
  • Nontypeable *Haemophilus influenzae* (NTHI) is a significant respiratory tract pathogen often found in biofilms.

Purpose of the Study:

  • To characterize the reactivity of human neutrophils (PMNs) towards NTHI released from biofilms.
  • To investigate the impact of a novel monoclonal antibody targeting biofilm matrix proteins on bacterial vulnerability.
  • To assess the role of PMN functions like engulfment, NETosis, and migration in response to released bacteria.

Main Methods:

  • Development of a monoclonal antibody targeting an essential biofilm matrix protein.
  • Incubation of human PMNs with dual-fluorescently labeled NTHI in different states (planktonic, biofilm, newly released).
  • Assessment of PMN engulfment, NETosis, and migratory activity using timelapse microscopy and flow cytometry.
  • Quantification of endotoxin, DNA, and cytokine/chemokine release (e.g., IL-8).

Main Results:

  • The monoclonal antibody induced rapid biofilm matrix collapse and released bacteria (NRel) in a vulnerable state.
  • PMN engulfment, NETosis, and migration were significantly enhanced when incubated with NTHI NRel compared to planktonic or biofilm NTHI.
  • PMNs incubated with NTHI NRel released increased levels of IL-8, promoting further PMN migration.
  • Bacterial endotoxin and DNA did not appear to be the primary drivers of the observed PMN activities.

Conclusions:

  • Newly released bacteria from biofilms (NRel) exhibit heightened susceptibility to host immune effectors, particularly PMNs.
  • Monoclonal antibody-induced bacterial release potentiates innate immune responses against NTHI biofilms.
  • This strategy, targeting biofilm matrix disruption, shows promise for facilitating host-mediated eradication of biofilm infections.

Related Concept Videos

Fimbriae, Pili, and Axial Filaments01:28

Fimbriae, Pili, and Axial Filaments

Fimbriae and pili are specialized bacterial surface structures that play pivotal roles in adhesion, genetic exchange, and motility. Composed primarily of pilin protein, these hairlike appendages are crucial for bacterial survival and pathogenicity in various environments.Fimbriae: Adhesion and PathogenicityFimbriae are fine, filamentous structures measuring 2–10 nanometers in diameter and are densely distributed on the bacterial cell surface. They facilitate bacterial adhesion to abiotic...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...